474 related articles for article (PubMed ID: 34335591)
21. The cardiometabolic conditions of psoriatic disease.
Toussirot E; Gallais-Sérézal I; Aubin F
Front Immunol; 2022; 13():970371. PubMed ID: 36159785
[TBL] [Abstract][Full Text] [Related]
22. Interplay between inflammation and thrombosis in cardiovascular pathology.
Stark K; Massberg S
Nat Rev Cardiol; 2021 Sep; 18(9):666-682. PubMed ID: 33958774
[TBL] [Abstract][Full Text] [Related]
23. Calcipotriol and betamethasone dipropionate exert additive inhibitory effects on the cytokine expression of inflammatory dendritic cell-Th17 cell axis in psoriasis.
Lovato P; Norsgaard H; Tokura Y; Røpke MA
J Dermatol Sci; 2016 Mar; 81(3):153-64. PubMed ID: 26794805
[TBL] [Abstract][Full Text] [Related]
24. Multi-glycoside of Tripterygium wilfordii Hook. f. ameliorates imiquimod-induced skin lesions through a STAT3-dependent mechanism involving the inhibition of Th17-mediated inflammatory responses.
Zhao J; Di T; Wang Y; Liu X; Liang D; Zhang G; Li P
Int J Mol Med; 2016 Sep; 38(3):747-57. PubMed ID: 27431437
[TBL] [Abstract][Full Text] [Related]
25. [Psoriasis syndrome with its comorbidities].
Piérard-Franchimont C; Piérard GE; Delvenne P; Hermanns-Lê T
Rev Med Liege; 2014 Oct; 69(10):555-8. PubMed ID: 25796750
[TBL] [Abstract][Full Text] [Related]
26. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach.
Späh F
Br J Dermatol; 2008 Aug; 159 Suppl 2():10-7. PubMed ID: 18700910
[TBL] [Abstract][Full Text] [Related]
27. Innate immunity in the pathogenesis of psoriasis.
Sweeney CM; Tobin AM; Kirby B
Arch Dermatol Res; 2011 Dec; 303(10):691-705. PubMed ID: 21863252
[TBL] [Abstract][Full Text] [Related]
28. Cytokine network in psoriasis revisited.
Michalak-Stoma A; Pietrzak A; Szepietowski JC; Zalewska-Janowska A; Paszkowski T; Chodorowska G
Eur Cytokine Netw; 2011 Dec; 22(4):160-8. PubMed ID: 22236965
[TBL] [Abstract][Full Text] [Related]
29. Characterization of skin Th17 transcriptional profiles in psoriatic patients under adalimumab biotherapy.
Buffiere-Morgado A; Couderc E; Delwail A; Favot L; Jegou JF; Solau E; Guillet G; Lecron JC; Morel F
Eur J Dermatol; 2017 Dec; 27(6):579-589. PubMed ID: 29171393
[TBL] [Abstract][Full Text] [Related]
30. T-helper 22 cells as a new player in chronic inflammatory skin disorders.
Mirshafiey A; Simhag A; El Rouby NM; Azizi G
Int J Dermatol; 2015 Aug; 54(8):880-8. PubMed ID: 26183243
[TBL] [Abstract][Full Text] [Related]
31. Pathogenesis of psoriasis and development of treatment.
Ogawa E; Sato Y; Minagawa A; Okuyama R
J Dermatol; 2018 Mar; 45(3):264-272. PubMed ID: 29226422
[TBL] [Abstract][Full Text] [Related]
32. Potential Immunological Links Between Psoriasis and Cardiovascular Disease.
Sajja AP; Joshi AA; Teague HL; Dey AK; Mehta NN
Front Immunol; 2018; 9():1234. PubMed ID: 29910818
[TBL] [Abstract][Full Text] [Related]
33. Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions.
Davidovici BB; Sattar N; Prinz J; Puig L; Emery P; Barker JN; van de Kerkhof P; Ståhle M; Nestle FO; Girolomoni G; Krueger JG
J Invest Dermatol; 2010 Jul; 130(7):1785-96. PubMed ID: 20445552
[TBL] [Abstract][Full Text] [Related]
34. Paeoniflorin inhibits skin lesions in imiquimod-induced psoriasis-like mice by downregulating inflammation.
Sun Y; Zhang J; Huo R; Zhai T; Li H; Wu P; Zhu X; Zhou Z; Shen B; Li N
Int Immunopharmacol; 2015 Feb; 24(2):392-399. PubMed ID: 25576402
[TBL] [Abstract][Full Text] [Related]
35. Effects of adalimumab therapy in adult subjects with moderate-to-severe psoriasis on Th17 pathway.
Balato A; Schiattarella M; Di Caprio R; Lembo S; Mattii M; Balato N; Ayala F
J Eur Acad Dermatol Venereol; 2014 Aug; 28(8):1016-24. PubMed ID: 24033358
[TBL] [Abstract][Full Text] [Related]
36. Psoriasis and its comorbidities.
Onumah N; Kircik LH
J Drugs Dermatol; 2012 May; 11(5 Suppl):s5-10. PubMed ID: 22644770
[TBL] [Abstract][Full Text] [Related]
37. "Inflammatory skin march" in atopic dermatitis and psoriasis.
Furue M; Kadono T
Inflamm Res; 2017 Oct; 66(10):833-842. PubMed ID: 28620798
[TBL] [Abstract][Full Text] [Related]
38. Long-term prognosis in patients with psoriasis.
Gulliver W
Br J Dermatol; 2008 Aug; 159 Suppl 2():2-9. PubMed ID: 18700909
[TBL] [Abstract][Full Text] [Related]
39. Platelets: Underestimated Regulators of Autoinflammation in Psoriasis.
Herster F; Karbach S; Chatterjee M; Weber ANR
J Invest Dermatol; 2021 Jun; 141(6):1395-1403. PubMed ID: 33810836
[TBL] [Abstract][Full Text] [Related]
40. Clinical Efficiency of Topical Calcipotriol/Betamethasone Treatment in Psoriasis Relies on Suppression of the Inflammatory TNFα - IL-23 - IL-17 Axis.
Kubin ME; Kokkonen N; Palatsi R; Hägg PM; Väyrynen JP; Glumoff V; Haapasaari KM; Hurskainen T; Tasanen K
Acta Derm Venereol; 2017 Apr; 97(4):449-455. PubMed ID: 27868150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
